NEUP
Neuphoria Therapeutics Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$3.77
+0.13%Margins
Gross margin
104.7%
EBITDA margin
217.1%
EBIT margin
230.7%
Net margin
272.0%
FCF margin
-567.8%
-96.8%
Return on equity
-81.8%
Return on assets
-82.0%
Return on invested capital
-0.29x
Asset turnover
$59.5M
Cash from operations
$3.60
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026